Evidence map›Paper›PMID 21670422›Full record

ArticleJournal of the National Cancer Institute2011

Personalized medicine and cancer supportive care: appropriate use of colony-stimulating factor support of chemotherapy.

Nicole M Kuderer, Gary H Lyman

Abstract readCommentEditorial
In one paragraph

Article in Journal of the National Cancer Institute, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Personalized cancer supportive care in COVID-19 era.Annals of oncology : official journal of the European Society for Medical Oncology · 2020
    Article
  5. Observational
  6. Development of a simplified multivariable model to predict neutropenic complications in cancer patients undergoing chemotherapy.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2018
    Article
  7. Article
  8. Burden of Chemotherapy-Induced Febrile Neutropenia Hospitalizations in US Clinical Practice, by Use and Patterns of Prophylaxis with Colony-Stimulating Factor.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2017
    Article
  9. Article
  10. Risk of chemotherapy-induced febrile neutropenia with early discontinuation of pegfilgrastim prophylaxis in US clinical practice.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2016
    Article
  11. Article
  12. Article
  13. A way forward on the medically appropriate use of white cell growth factors.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2012
    Review
  14. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Nicole M Kuderer
Gary H Lyman

Funding

Venous Thrombosis in Cancer Outpatients: Prevention and Role of Tissue FactorR01HL095109 · NHLBI · UNIVERSITY OF ROCHESTER · PI FRANCIS, CHARLES W. · 2008 to 2012
$3.2M
NCI NIH HHS RC2CA14041-01NHLBI NIH HHS 1R01HL095109-01
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Precision MedicineAntineoplastic AgentsClinical Trials as TopicColony-Stimulating FactorsDrug Administration ScheduleDrug PrescriptionsFeverHealth Maintenance OrganizationsHumansMedical OncologyNeoplasmsNeutropeniaPractice Guidelines as TopicPrimary PreventionRisk FactorsSecondary PreventionAntineoplastic AgentsColony-Stimulating Factors

Identifiers

PMID21670422
PMCPMC3119650

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.